Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Daiichi Closing Indian Site As Global Restructuring Continues

Jan 12 2017

• By Anju Ghangurde and Ian Haydock

India_moneybox_1200x675

Related Content

Kite Flies CAR-T Into Asia With Daiichi Sankyo, Fosun Deals

Jan 11 2017

Daiichi Sankyo Lays Out Priorities As It Pursues Oncology Ambitions

Dec 15 2016

U3 Shut Down As Daiichi Sankyo Streamlines R&D

Dec 03 2015

Daiichi Arbitration Case Bares Trail Of Deception At Ranbaxy

Aug 11 2016

Daiichi Sankyo Shutting UK Site As Global Cost Drive Continues

Feb 10 2016

Daiichi-Sankyo Slashing 1,000+ US Jobs Ahead Of Benicar Expiry

Oct 20 2015

Sandoz shutters formulations R&D unit, Indian generic plans intact

Nov 30 2012

Related Companies

Daiichi Sankyo Co., Ltd.

Ranbaxy Laboratories Limited

Kite Pharma, Inc.

U3 Pharma AG

Sun Pharmaceutical Industries Ltd.

Novartis AG

Additional Topics

India Asia Pacific Commercial Companies BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window